114 related articles for article (PubMed ID: 21219850)
1. Intraperitoneal AAV9-shRNA inhibits target expression in neonatal skeletal and cardiac muscles.
Mayra A; Tomimitsu H; Kubodera T; Kobayashi M; Piao W; Sunaga F; Hirai Y; Shimada T; Mizusawa H; Yokota T
Biochem Biophys Res Commun; 2011 Feb; 405(2):204-9. PubMed ID: 21219850
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal administration of AAV9-shRNA inhibits target gene expression in the dorsal root ganglia of neonatal mice.
Machida A; Kuwahara H; Mayra A; Kubodera T; Hirai T; Sunaga F; Tajiri M; Hirai Y; Shimada T; Mizusawa H; Yokota T
Mol Pain; 2013 Jul; 9():36. PubMed ID: 23866078
[TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of shRNA by AAV9 provides highly efficient knockdown of ubiquitously expressed GFP in mouse heart, but not liver.
Piras BA; O'Connor DM; French BA
PLoS One; 2013; 8(9):e75894. PubMed ID: 24086659
[TBL] [Abstract][Full Text] [Related]
4. Efficient Gene Suppression in Dorsal Root Ganglia and Spinal Cord Using Adeno-Associated Virus Vectors Encoding Short-Hairpin RNA.
Enomoto M; Hirai T; Kaburagi H; Yokota T
Methods Mol Biol; 2016; 1364():277-90. PubMed ID: 26472458
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice.
Hirai T; Enomoto M; Machida A; Yamamoto M; Kuwahara H; Tajiri M; Hirai Y; Sotome S; Mizusawa H; Shinomiya K; Okawa A; Yokota T
Hum Gene Ther Methods; 2012 Apr; 23(2):119-27. PubMed ID: 22583159
[TBL] [Abstract][Full Text] [Related]
6. AAV9 Delivery of shRNA to the Mouse Heart.
Wakimoto H; Seidman JG; Foo RSY; Jiang J
Curr Protoc Mol Biol; 2016 Jul; 115():23.16.1-23.16.9. PubMed ID: 27366889
[TBL] [Abstract][Full Text] [Related]
7. Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.
Pulicherla N; Shen S; Yadav S; Debbink K; Govindasamy L; Agbandje-McKenna M; Asokan A
Mol Ther; 2011 Jun; 19(6):1070-8. PubMed ID: 21364538
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase-mediated desialylation augments AAV9-mediated gene expression in skeletal muscle.
Zhu H; Wang T; John Lye R; French BA; Annex BH
J Gene Med; 2018 Sep; 20(9):e3049. PubMed ID: 30101537
[TBL] [Abstract][Full Text] [Related]
9. Suppression of transforming growth factor β1 in lung alveolar epithelium-derived cells using adeno-associated virus type 2/5 vectors to carry short hairpin RNA.
Kage H; Sugimoto K; Sano A; Kitagawa H; Nagase T; Ohishi N; Takai D
Exp Lung Res; 2011 Apr; 37(3):175-85. PubMed ID: 21269064
[TBL] [Abstract][Full Text] [Related]
10. Post-Natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected].
Wang CH; Chan YM; Tang RH; Xiao B; Lu P; Keramaris-Vrantsis E; Zheng H; Qiao C; Jiang J; Li J; Ma HI; Lu Q; Xiao X
Am J Pathol; 2011 Jan; 178(1):261-72. PubMed ID: 21224063
[TBL] [Abstract][Full Text] [Related]
11. Development of an AAV9-RNAi-mediated silencing strategy to abrogate TRPM4 expression in the adult heart.
Medert R; Jungmann A; Hildebrand S; Busch M; Grimm D; Flockerzi V; Müller OJ; Most P; Schumacher D; Freichel M
Pflugers Arch; 2021 Mar; 473(3):533-546. PubMed ID: 33580817
[TBL] [Abstract][Full Text] [Related]
12. shRNA-mediated gene knockdown in skeletal muscle.
Golzio M; Escoffre JM; Teissié J
Methods Mol Biol; 2012; 798():491-501. PubMed ID: 22130856
[TBL] [Abstract][Full Text] [Related]
13. Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy.
Fechner H; Sipo I; Westermann D; Pinkert S; Wang X; Suckau L; Kurreck J; Zeichhardt H; Müller O; Vetter R; Erdmann V; Tschope C; Poller W
J Mol Med (Berl); 2008 Sep; 86(9):987-97. PubMed ID: 18548221
[TBL] [Abstract][Full Text] [Related]
14. AAV-based shRNA silencing of NF-κB ameliorates muscle pathologies in mdx mice.
Yang Q; Tang Y; Imbrogno K; Lu A; Proto JD; Chen A; Guo F; Fu FH; Huard J; Wang B
Gene Ther; 2012 Dec; 19(12):1196-204. PubMed ID: 22278411
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart.
Wang Z; Zhu T; Qiao C; Zhou L; Wang B; Zhang J; Chen C; Li J; Xiao X
Nat Biotechnol; 2005 Mar; 23(3):321-8. PubMed ID: 15735640
[TBL] [Abstract][Full Text] [Related]
16. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.
Blankinship MJ; Gregorevic P; Allen JM; Harper SQ; Harper H; Halbert CL; Miller AD; Chamberlain JS
Mol Ther; 2004 Oct; 10(4):671-8. PubMed ID: 15451451
[TBL] [Abstract][Full Text] [Related]
17. Effective knockdown of multiple target genes by expressing the single transcript harbouring multi-cistronic shRNAs.
Junn HJ; Kim JY; Seol DW
Biochem Biophys Res Commun; 2010 Jun; 396(4):861-5. PubMed ID: 20451494
[TBL] [Abstract][Full Text] [Related]
18. An effective gene-knockdown using multiple shRNA-expressing adenovirus vectors.
Motegi Y; Katayama K; Sakurai F; Kato T; Yamaguchi T; Matsui H; Takahashi M; Kawabata K; Mizuguchi H
J Control Release; 2011 Jul; 153(2):149-53. PubMed ID: 21515317
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus-delivered short hairpin-structured RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: a preclinical study.
Sun A; Tang J; Terranova PF; Zhang X; Thrasher JB; Li B
Int J Cancer; 2010 Feb; 126(3):764-74. PubMed ID: 19642108
[TBL] [Abstract][Full Text] [Related]
20. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.
Inagaki K; Fuess S; Storm TA; Gibson GA; Mctiernan CF; Kay MA; Nakai H
Mol Ther; 2006 Jul; 14(1):45-53. PubMed ID: 16713360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
